Johnson & Johnson submits robotic surgical system for De Novo classification

Johnson & Johnson has announced the submission of its Ottava Robotic Surgical System for De Novo classification from the US Food and Drug Administration (FDA). The Ottava system encompasses surgical instrumentation and will, in future, be connected to the Polyphonic digital ecosystem. It is intended to address unmet need for surgeons.The De Novo classification request […] The post Johnson & Johnson submits robotic surgical system for De Novo classification appeared first on Pharmafile.

Continue reading →